Clinical Trial

A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors

Name: A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors — clinical trial record (NCT07354711)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The study is being conducted to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of 3H-10000 in the treatment of unresectable or metastatic solid tumors .

Trial Details

NCT Number	NCT07354711
Lead Sponsor	3H Pharmaceuticals Co., Ltd.
Conditions	Lung Cancer, Stomach Cancer
Enrollment	170 participants
Start Date	2026-01-04
Primary Completion	2028-01 (estimated)
Study Completion	2029-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-21